Overview

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if favipiravir is effective in reducing the time to resolution of influenza symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
MDVI, LLC
Collaborator:
MediVector, Inc.
Treatments:
Favipiravir